NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$4.27
-0.12 (-2.73%)
As of Sep 28, 10:42 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +98.4% upside
Low Target $5.74
Average Target $8.47
High Target $10.28
Current Price $4.27
Current
$4.27
Target
$8.47
$5.74 $8.47 avg $10.28
Scenario Analysis
Bear Case
$5.74
34.4%
Low target
Base Case
$8.47
+98.4%
Avg target
Bull Case
$10.28
+140.7%
High target
Risk/Reward
4.1x
Highly favorable
Price in Context
52-Week High
$60.00
-92.9% from high
52-Week Low
$4.00
+6.7% from low
Target vs 52W High
$8.47
-85.9% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Strong Buy 34 79% $293.85 -22.2%
ABT
Abbott Laboratories
Strong Buy 33 76% $123.47 +22.3%
ISRG
Intuitive Surgical Inc
Buy 40 73% $219.77 -47.0%
MDT
Medtronic Plc
Buy 34 68% $192.46 +115.0%
CVS
Cvs Health Corp
Strong Buy 33 85% $162.09 +84.5%
SYK
Stryker Corp
Strong Buy 34 79% $338.36 +22.9%
MCK
Mckesson Corp
Strong Buy 24 79% $307.39 -64.1%
HCA
Hca Healthcare Inc
Buy 30 57% $118.82 -72.5%